+91 9311595648

[email protected]

Enquire Now

[falcon_news_ticker]

India’s Pharma Industry is Shifting to High-Value Drugs​

India’s Pharma Industry is Shifting to High-Value Drugs

Over the past few decades, China has met more than 70% of India’s demand for medicines and APIs. To reduce this dependence, India’s pharma industry is shifting to high-value drugs. India is working towards expanding high-value medicines, complex chemistry, and advanced therapies by investing in domestic manufacturing units.

Falcon Freight manages Export of Pharmaceutical Products from India with proper documentation, customs clearance and secure air and sea freight.

Dependence on China Remains a Challenge

China is the largest exporter of bulk medicines and APIs to India. In FY25, India imported drugs worth $4.35 billion, of which 73.71% came from China. Several Indian businesses depend on Chinese APIs because they are around 40% cheaper than the domestic alternatives. Therefore, China is one of the biggest challenges for Indian manufacturers.

Growth in India’s Local Industries

To overcome the dependence on China, the Indian government is launching several initiatives to strengthen the pharma sector. For example, in June 2026, the Pharmaceutical Production Linked Scheme drew ₹46,744 crore in committed investments and generated cumulative sales of ₹4.03 lakh crore. Likewise, under the Bulk Drugs PLI Scheme, investments had reached ₹5,210.74 crore, with 39 manufacturing projects commissioned.
This came as a result of increasing local and global demand for diabetes, cancer and metabolic drugs. As a result, Indian manufacturers shifted from volume-led production to higher-value medicines, complex chemistry, and advanced therapies. Now, their focus is on specialised therapies, advanced manufacturing, and local API production.

Boost In India’s Pharma Exports

India is currently witnessing a growth in pharmaceutical exports. With investment support in advanced manufacturing and quality management systems, India’s pharma industry is making significant progress in strengthening global competitiveness and technological capabilities. Moreover, private-sector investments are further helping Indian manufacturers to boost production and focus on innovation-driven manufacturing. As a result, Indian pharma exports reached $30.47 billion in FY25, rising 6.8% year on year.
Way Forward

As India’s pharma industry is shifting to high-value drugs, Indian manufacturers can reduce dependence on Chinese goods. Furthermore, the demand for India’s drugs will increase in the upcoming years. With private investments and government initiatives, local drug producers will benefit in the long run.
Falcon Freight handles Pharmaceutical Export Shipping from India with proper documentation, customs clearance and temperature-sensitive cargo support.

At Falcon, we help businesses export and import pharmaceutical products. We help businesses throughout their trading journey, from documentation to freight forwarding and logistics. Moreover, we provide cold-chain solutions and specialised packaging for shipping pharmaceuticals. Contact our team at +91-9311595648 or email us at [email protected] for a free quote on your shipment today.
Scroll to Top